232 related articles for article (PubMed ID: 30897019)
1. Patient-Reported Nonadherence with Glaucoma Therapy.
Wolfram C; Stahlberg E; Pfeiffer N
J Ocul Pharmacol Ther; 2019 May; 35(4):223-228. PubMed ID: 30897019
[No Abstract] [Full Text] [Related]
2. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
Rees G; Leong O; Crowston JG; Lamoureux EL
Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).
Vandenbroeck S; De Geest S; Dobbels F; Fieuws S; Stalmans I; Zeyen T
J Glaucoma; 2011 Sep; 20(7):414-21. PubMed ID: 21048510
[TBL] [Abstract][Full Text] [Related]
4. Glaucoma patient expression of medication problems and nonadherence.
Slota C; Sayner R; Vitko M; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Sleath B
Optom Vis Sci; 2015 May; 92(5):537-43. PubMed ID: 25875690
[TBL] [Abstract][Full Text] [Related]
5. [Preservative-free glaucoma treatment : Selection of the correct treatment in 1 min].
Pfennigsdorf S; Eschstruth P
Ophthalmologe; 2016 May; 113(5):409-15. PubMed ID: 26563361
[TBL] [Abstract][Full Text] [Related]
6. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
[TBL] [Abstract][Full Text] [Related]
7. Managing Side Effects on Ocular Surface Caused by Glaucoma Eye Drops.
Ferreras A; Figus M; Fogagnolo P; Iester M; Frezzotti P
Curr Med Chem; 2019; 26(22):4223-4224. PubMed ID: 31612807
[No Abstract] [Full Text] [Related]
8. Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment.
Tiedemann D; Mouhammad ZA; Utheim TP; Dartt DA; Heegaard S; Petrovski G; Kolko M
J Glaucoma; 2019 Apr; 28(4):325-333. PubMed ID: 30585937
[TBL] [Abstract][Full Text] [Related]
9. Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.
Park MH; Kang KD; Moon J;
Jpn J Ophthalmol; 2013 Jan; 57(1):47-56. PubMed ID: 23065047
[TBL] [Abstract][Full Text] [Related]
10. Preservatives in glaucoma medication.
Steven DW; Alaghband P; Lim KS
Br J Ophthalmol; 2018 Nov; 102(11):1497-1503. PubMed ID: 29973365
[TBL] [Abstract][Full Text] [Related]
11. Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016.
Chamard C; Larrieu S; Baudouin C; Bron A; Villain M; Daien V
Acta Ophthalmol; 2020 Nov; 98(7):e876-e881. PubMed ID: 32232968
[TBL] [Abstract][Full Text] [Related]
12. Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease.
Goldberg I; Graham SL; Crowston JG; d'Mellow G;
Clin Exp Ophthalmol; 2015 Apr; 43(3):214-20. PubMed ID: 25196488
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
Salyani A; Birt C
Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
[TBL] [Abstract][Full Text] [Related]
14. Communication Predicts Medication Self-Efficacy in Glaucoma Patients.
Carpenter DM; Blalock SJ; Sayner R; Muir KW; Robin AL; Hartnett ME; Giangiacomo AL; Tudor GE; Sleath BL
Optom Vis Sci; 2016 Jul; 93(7):731-7. PubMed ID: 27003815
[TBL] [Abstract][Full Text] [Related]
15. Preservative-free treatment in glaucoma: who, when, and why.
Stalmans I; Sunaric Mégevand G; Cordeiro MF; Hommer A; Rossetti L; Goñi F; Heijl A; Bron A
Eur J Ophthalmol; 2013; 23(4):518-25. PubMed ID: 23483513
[TBL] [Abstract][Full Text] [Related]
16. Patient-centered communication to assess and enhance patient adherence to glaucoma medication.
Hahn SR
Ophthalmology; 2009 Nov; 116(11 Suppl):S37-42. PubMed ID: 19837259
[TBL] [Abstract][Full Text] [Related]
17. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
[TBL] [Abstract][Full Text] [Related]
18. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.
Sleath B; Blalock S; Covert D; Stone JL; Skinner AC; Muir K; Robin AL
Ophthalmology; 2011 Dec; 118(12):2398-402. PubMed ID: 21856009
[TBL] [Abstract][Full Text] [Related]
19. The Relationship of Self-Report and Medication Possession With Glaucoma Medication Administration Success.
Hein AM; Rosdahl JA; Bosworth HB; Woolson SL; Olsen MK; Kirshner MA; Muir KW
J Glaucoma; 2019 Mar; 28(3):e46-e48. PubMed ID: 30822299
[TBL] [Abstract][Full Text] [Related]
20. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
